Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IBS01 - My Oligometastatic Oncogene Driven Patient (Ticketed Session)
- 07:00 - 08:00
- 9/08/2019
- Location: Tokyo (1982)
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: Targeted Therapy
-
+
IBS01.02 - Strategies Treatment After Oligoprogression
07:20 - 07:40 | Presenter: Federico Cappuzzo | Author(s): Lorenza Landi
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-45 - Immune-Oncology Gene Expression Profiles Allow Lung Cancer Patients’ Stratification and Identification of Responders to Immunotherapy
09:45 - 09:45 | Presenter: Fabrizio Tabbò | Author(s): Laura Annaratone, Alberto Nocifora, Chiara Vignale, Simona Carnio, Jasna Metovic, Francesca Veneziano, Simona Scodes, Alessandro Russo, Tindara Franchina, Claudio Sini, Simona Coco, Pietro Garlatti, Scotti Vieri, Vincenzo Adamo, Simona Boccardo, Francesco Grossi, Federico Cappuzzo, MAURO GIULIO PAPOTTI, luisella Righi, francesco Passiglia, Silvia Novello
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-03 - Molecular Determinants for Lorlatinib Activity in ROS1 Positive NSCLC: Results of the Prospective PFROST Trial
09:45 - 09:45 | Presenter: Lorenza Landi | Author(s): marcello Tiseo, Lukas C Heukamp, Roopika Menon, Gianluca Spitaleri, Diego Luigi Cortinovis, Angelo Delmonte, Domenico Galetta, Manolo D'Arcangelo, Federica D'Incà, Miriam Bertrand, Balázs Jóri, Angela Zacher, Cesare Gridelli, Silvia Novello, Rita Chiari, Claudio Verusio, Lucio Crino, Federico Cappuzzo
- Abstract
Loading... -
+
P1.14-26 - ALK Fusion Variant Detection by Targeted RNA-Seq in TKIs Treated ALK-Positive Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Fabrizio Tabbò | Author(s): Elisa Gobbini, Lucia Anna Muscarella, Angelica Rigutto, Domenico Trombetta, Antonio Bonfitto, Domenico Galetta, Evaristo Maiello, Olga Martelli, marcello Tiseo, Paola Bordi, Vieri Scotti, Laura Ghilardi, Vanesa Gregorc, Concetta Sergi, Sara Pilotto, Alessandro Del Conte, Federico Cappuzzo, Diego Luigi Cortinovis, Giorgia Osman, Claudia Bareggi, Massimo Di Maio, Antonio Rossi, Giulio Rossi, Emilio Bria, Marco Volante, Giorgio Vittorio Scagliotti, Paolo Graziano, Silvia Novello, luisella Righi
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-15 - Phase II Single Arm Study of CABozantinib in Non-Small Cell Lung Cancer Patients with MET Deregulation (CABinMET)
10:15 - 10:15 | Presenter: Manolo D'Arcangelo | Author(s): Davide Tassinari, Filippo De Marinis, Angelo Delmonte, Domenico Galetta, Fabiana Letizia Cecere, Sara Pilotto, francesca Zanelli, Laura Bonanno, Lorenza Landi, Federica D'Incà, Federico Cappuzzo
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-49 - Nivolumab Plus Ipilimumab (NI) Versus Chemotherapy Plus Nivolumab (CN) in Squamous Cell Lung Cancer (SqCLC): The SQUINT Trial
10:15 - 10:15 | Presenter: Lorenza Landi | Author(s): Laura Bonanno, Angelo Delmonte, Maximilian Papi, Valeria Stati, Vincenzo Minotti, Chiara Bennati, Federica D'Incà, Maria Rita Migliorino, Stefani Gori, Antonio Santo, Francovito Piantedosi, Antonio Russo, Federico Cappuzzo
- Abstract
Loading...
-
+
PR04 - Press Conference
- 10:45 - 11:30
- 9/10/2019
- Location: CC7.1 A&B
- Type: Press Conference
- Track:
-
+
PR04.03 - IMpower131: Final OS Results of Carboplatin + Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC
10:58 - 11:06
- Abstract
No abstract available for this presentation
-
+
OA14 - Update of Phase 3 Trials and the Role of HPD
- 11:30 - 13:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Julie R Brahmer, Diego Signorelli
-
+
OA14.02 - IMpower131: Final OS Results of Carboplatin + Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC
11:40 - 11:50 | Presenter: Federico Cappuzzo | Author(s): Robert Jotte, Ihor Vynnychenko, Daniil Stroyakovskiy, Delvys Rodriguez Abreu, Maen Hussein, Ross Soo, Henry J Conter, Toshiyuki Kozuki, KC Huang, Vilma Graupner, Shawn Sun, Tien Hoang, Helen Jessop, Mark McCleland, Marcus Ballinger, Alan Sandler, Mark A Socinski
- Abstract
Loading...